{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:15:42Z","timestamp":1792163742268,"version":"4.4.0"},"reference-count":27,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2007,12,7]],"date-time":"2007-12-07T00:00:00Z","timestamp":1196985600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:p><jats:bold>Objectives:\u2002<\/jats:bold> To provide an accurate estimation of the magnitude of effect of lithium in short\u2010term efficacy studies conducted in patients with moderate to severe manic episode.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> All placebo\u2010controlled randomized studies submitted to the Medicines Evaluation Board (MEB) in which lithium was used as the third study arm were selected for the meta\u2010analysis. The studies were part of registration files submitted to the MEB between the years 1997 and 2005. In addition, Medline and EMbase searches were conducted with the key words \u2018manic\u2019 (\u2018mania\u2019 for the EMbase search) and \u2018placebo\u2019 in order to identify additional placebo\u2010controlled studies of lithium. This search was updated until March 1, 2006. Two effect size indicators were used based on the primary outcome measure of each study: Cohen's standardized effect size based on the difference in mean change from baseline, and numbers needed to treat (NNT) based on the difference in treatment response defined as \u226550% improvement from baseline on day 21.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Six studies were identified. They involved a combined total of 470 patients in the lithium groups and 562 in the placebo groups. The overall standardized effect size was 0.40 [95% confidence interval (CI): 0.28, 0.53] and the overall NNT for response was 6 (95% CI: 4, 13). In the placebo groups response rates varied from 21% to 47%.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> The results indicate that lithium is an effective drug in the treatment of moderate to severe manic episode. The variability in placebo response indicates that a placebo control arm in efficacy studies among patients with moderate to severe manic episode is necessary.<\/jats:p>","DOI":"10.1111\/j.1399-5618.2007.00445.x","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T14:31:01Z","timestamp":1284388261000},"page":"793-798","source":"Crossref","is-referenced-by-count":36,"title":["Magnitude of effect of lithium in short\u2010term efficacy studies of moderate to severe manic episode"],"prefix":"10.1111","volume":"9","author":[{"given":"Jitschak G","family":"Storosum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Wohlfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aart","family":"Schene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Elferink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J","family":"Van Zwieten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim van den","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,12,7]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2005.01.004"},{"issue":"9","key":"e_1_2_5_3_2","first-page":"35","article-title":"Efficacy of lithium in mania and maintenance therapy of bipolar disorder","volume":"61","author":"Bowden CL","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_5_4_2","volume-title":"Note for Guidance on Clinical Investigation of Medicinal Products for the Treatment and Prevention of Bipolar Disorder. Evaluation of Medicines for Human Use","author":"European Agency for the Evaluation of Medicinal Products","year":"2001"},{"key":"e_1_2_5_5_2","volume-title":"Note for Guidance on Choice of Control Group in Clinical Trials","author":"European Agency for the Evaluation of Medicinal Products","year":"2000"},{"key":"e_1_2_5_6_2","volume-title":"Note for Guidance on Good Clinical Practice","author":"European Agency for the Evaluation of Medicinal Products","year":"2000"},{"key":"e_1_2_5_7_2","first-page":"20","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen J","year":"1988"},{"key":"e_1_2_5_8_2","unstructured":"Centre for Evidence\u2010based Medicine Department of Medicine Toronto General Hospital.2004.http:\/\/www.cebm.utoronto.ca\/glossary(Accessed November 29 2006)."},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta\u2010analysis in clinical trials","volume":"7","author":"DerSimonian R","year":"1996","journal-title":"Control Clin Trials"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510360044034"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0116"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2006.00276.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770310043002"},{"key":"e_1_2_5_15_2","volume-title":"Practice Guideline for the Treatment of Patients with Bipolar Disorder","author":"American Psychiatric Association, 2002"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2003.10.003"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group","volume":"156","author":"Tohen M","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.9.841"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.4.741"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000169068.34322.70"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.9.1651"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106059693"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0405"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2004.06.003"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.3.229"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2005.02.006"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00311-X"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.3.262"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2007.00445.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2007.00445.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T11:58:21Z","timestamp":1696939101000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2007.00445.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1111\/j.1399-5618.2007.00445.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2007.00445.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}